Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents.

By I. Iakovou, T. Schmidt, E. Bonizzoni, L. Ge, G. Sangiorgi, G. Stanković, F. Airoldi, A. Chieffo, M. Montorfano, M. Carlino and 6 more. Journal of the American Medical Association (JAMA), 2005

2,926 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/0c5d191f71f7ab005fd74b0cedf42aa5226d9b9b

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. J. Chiu
2. Rick A. Nishimura
3. Robert M. Califf
4. Harvey D. White
5. Volkmar Falk
6. Stephan Windecker
7. C. Yancy

In Pulmonary and Respiratory Medicine

1. Shu Chien
2. Renu Virmani

In Surgery

1. Renu Virmani
2. A. Finn
3. F. Kolodgie
4. Shu Chien
5. Robert M. Califf
6. Harvey D. White
7. J. Chiu
8. Erling Falk

Citations in the corpus

• A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. (2006, background): “While every subgroup appears clinically and statistically homogeneous, the risk of antiplatelet discontinuation appear far greater after PCI with drug-eluting stent implantation, as reported by Iakovou et al.,31 than in any other study group.”
• Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. (2006, background): “eceiving DES have suggested that the window of thromotic risk at sites where these stents have been deployed xtends far beyond that for BMS (7,8).”
• Correlates and Long-Term Outcomes of Angiographically Proven Stent Thrombosis With Sirolimus- and Paclitaxel-Eluting Stents (2006, neutral): “GP IIb/IIIa use, n (%) 12 (30) 374 (13) 0.”
• Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. (2007, background): “Premature discontinuation of this minimum antiplatelet therapy has been associated with stent thrombosis.(4,5) However, studies of late thrombosis events among patients with a drug-eluting stent have cast doubt on whether the recommended regimens are sufficient.”